+1,650.0%
MPWR vs GSK
+76.8%
+1,573.2%
-51.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.4% | -2.7% | +2.3% | +0.7% |
| 7D | -0.6% | -4.2% | +3.6% | +1.1% |
| 30D | -13.1% | -7.5% | -5.5% | -10.4% |
| 3M | -21.7% | -3.3% | -18.5% | -21.6% |
| 6M | +19.5% | -9.3% | +28.8% | +22.9% |
| YTD | +34.9% | +1.6% | +33.3% | +31.1% |
| 1Y | +42.0% | +25.5% | +16.5% | +23.8% |
| 3Y | +148.8% | +49.3% | +99.5% | +90.6% |
| 5Y | +156.8% | +46.7% | +110.1% | +91.7% |
| 10Y | +1,650.0% | +76.8% | +1,573.2% | +1,054.1% |
| All | +1,650.0% | +76.8% | +1,573.2% | +1,054.1% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling